OR WAIT null SECS
PAREXEL, a global biopharmaceutical services provider, today announced that it has opened an office in Lima, Peru to provide regulatory consulting and clinical research capabilities.
Boston, MA, November 20, 2008—PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it has opened an office in Lima, Peru to provide regulatory consulting and clinical research capabilities. With the addition of the Peru office, PAREXEL now has locations throughout five important biopharmaceutical centers in Latin America, which also include Argentina, Brazil, Chile, and Mexico. This expansion further strengthens the Company's position as one of the largest biopharmaceutical services providers in this emerging region for clinical development.
"PAREXEL has had a presence in Latin America since 1997, and a long-term commitment to providing clients with high quality services in the region. Due to the increasing globalization of clinical research, client demand for our capabilities in Latin America has been steadily increasing, and over the last seven years PAREXEL has experienced double-digit growth in the region. Peru is a key growing market in Latin America, with approximately 28 million people. The opening of our Peru office marks a significant opportunity for clients to further expand their clinical development programs throughout Latin America,” said Josef H. von Rickenbach, Chairman and Chief Executive Officer of PAREXEL. "Our experts in Latin America manage complex clinical trials on a regional and worldwide scale. Included among the broad array of services we provide, we are helping clients to navigate regulatory environments, identify qualified investigators, and access diverse patient populations throughout the region.”
Capabilities provided by PAREXEL's Latin American locations include regulatory advice for clinical development, as well as a broad range of services including project management, site management, data management, medical affairs, biostatistics, and bioanalysis for the conduct of Phase II-IV studies. PAREXEL's clinical logistics team in Latin America, with in-depth expertise in import and export regulations, coordinates multinational logistics and helps clients effectively manage global clinical trial supply requirements. PAREXEL's Latin American locations offer extensive late phase development capabilities including observational studies, patient registries, outcomes research, and expanded access programs.
For more information about PAREXEL's global Clinical Research Services, visit http://www.parexel.com/clinical_research.html.